HIGHLIGHTS
- who: Alejandro Romero and José Marco-Contelles from the University of Texas Health Science Center at Houston, USA have published the research: Melatonin and Nitrones As Potential Therapeutic Agents for Stroke, in the Journal: (JOURNAL)
SUMMARY
Stroke is a disease of aging, affecting an increasing number of people worldwide, and the main cause of disability (Flynn et_al, 2008; Mathers et_al, 2009). Under deprivation of oxygen and glucose, cell death occurs in two phases: (a) first cell death from anoxia/hypoxia and energy depletion, followed by; and_(b) reperfusion that increase oxidative stress and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.